The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 21, 2020
Filed:
Dec. 20, 2013
Applicant:
Abbott Laboratories, Abbott Park, IL (US);
Inventors:
Geralyn Duska-Mcewen, Columbus, OH (US);
Sarah Comstock, East Lansing, MI (US);
Sharon Donovan, Champaign, IL (US);
Rachael Buck, Gahanna, OH (US);
Joseph Schaller, Reynoldsburg, OH (US);
Assignee:
ABBOTT LABORATORIES, Abbott Park, IL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7028 (2006.01); A61K 31/702 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 31/015 (2006.01); A61K 31/202 (2006.01); A23L 5/00 (2016.01); A23L 33/125 (2016.01); A23L 33/21 (2016.01); A23L 2/52 (2006.01); A23L 33/10 (2016.01); A23L 29/30 (2016.01); A23L 33/105 (2016.01); A23L 33/15 (2016.01); A23L 33/115 (2016.01); A23L 33/12 (2016.01); A23L 33/00 (2016.01); A23L 33/22 (2016.01); A23L 7/00 (2016.01); A23L 21/00 (2016.01); A23L 9/00 (2016.01);
U.S. Cl.
CPC ...
A61K 31/7028 (2013.01); A23L 2/52 (2013.01); A23L 5/00 (2016.08); A23L 29/30 (2016.08); A23L 33/10 (2016.08); A23L 33/105 (2016.08); A23L 33/115 (2016.08); A23L 33/12 (2016.08); A23L 33/125 (2016.08); A23L 33/15 (2016.08); A23L 33/21 (2016.08); A23L 33/22 (2016.08); A23L 33/40 (2016.08); A61K 9/0095 (2013.01); A61K 31/015 (2013.01); A61K 31/202 (2013.01); A61K 31/702 (2013.01); A61K 45/06 (2013.01); A23L 7/00 (2016.08); A23L 9/00 (2016.08); A23L 21/00 (2016.08); A23V 2002/00 (2013.01); A23V 2200/324 (2013.01); A23V 2250/032 (2013.01); A23V 2250/0612 (2013.01); A23V 2250/154 (2013.01); A23V 2250/1578 (2013.01); A23V 2250/1586 (2013.01); A23V 2250/1588 (2013.01); A23V 2250/1592 (2013.01); A23V 2250/1598 (2013.01); A23V 2250/16 (2013.01); A23V 2250/161 (2013.01); A23V 2250/1608 (2013.01); A23V 2250/1612 (2013.01); A23V 2250/1614 (2013.01); A23V 2250/1626 (2013.01); A23V 2250/1642 (2013.01); A23V 2250/1842 (2013.01); A23V 2250/28 (2013.01); A23V 2250/304 (2013.01); A23V 2250/5036 (2013.01); A23V 2250/5054 (2013.01); A23V 2250/5108 (2013.01); A23V 2250/5114 (2013.01); A23V 2250/5424 (2013.01); A23V 2250/5488 (2013.01); A23V 2250/54246 (2013.01); A23V 2250/54252 (2013.01); A23V 2250/61 (2013.01); A23V 2250/628 (2013.01); A23V 2250/702 (2013.01); A23V 2250/705 (2013.01); A23V 2250/706 (2013.01); A23V 2250/708 (2013.01); A23V 2250/7044 (2013.01); A23V 2250/7046 (2013.01); A23V 2250/7056 (2013.01); A23V 2250/7058 (2013.01); A23V 2250/712 (2013.01); A23V 2250/7106 (2013.01); A23V 2250/72 (2013.01);
Abstract
Disclosed is a nutritional composition for use in modulating or reducing inflammation in an adult or elderly individual in need thereof. In some aspects, the nutritional composition comprises a neutral human milk oligosaccharide.